Neurology residency program as factor associated with thrombolysis utilization in acute stroke.
Where this comes from
- Record sourced from PubMed, PMID 24186909.
- Also identified by DOI 10.1212/01.wnl.0000436932.01916.00.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Despite strong evidence on the safety and efficacy of IV alteplase up to 4.5 hours after ischemic stroke (IS) symptom onset and increased use of thrombolysis over recent decades, this treatment remains underused and accessible to only a fraction of patients. The rate of thrombolysis in the United States is 3.4%-5.2% of all stroke cases. Several studies have identified barriers to thrombolysis delivery, but other as yet unmeasured factors may also underlie these barriers, thereby influencing rates of thrombolysis utilization and access.
Medical subject headings
- Brain Ischemia
- Hospitals
- Internship and Residency
- Neurology
- Stroke
- Thrombolytic Therapy